𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Understanding Firm, Physician and Consumer Choice Behavior in the Pharmaceutical Industry

✍ Scribed by Puneet Manchanda; Dick R. Wittink; Andrew Ching; Paris Cleanthous; Min Ding; Xiaojing J. Dong; Peter S. H. Leeflang; Sanjog Misra; Natalie Mizik; Sridhar Narayanan; Thomas Steenburgh; Jaap E. Wieringa; Marta Wosinska; Ying Xie

Book ID
106454762
Publisher
Springer US
Year
2005
Tongue
English
Weight
145 KB
Volume
16
Category
Article
ISSN
0923-0645

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The relative impact of actual and potent
The relative impact of actual and potential rivalry on firm profitability in the pharmaceutical industry
✍ Karel Cool; Lars-Hendrik RΓΆller; Benoit Leleux πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 95 KB πŸ‘ 3 views

This paper estimates the effects of actual and potential rivalry on profitability of firms in the U.S. pharmaceutical industry during the 20-year period 1963-82. The results show that during the 1960s actual rivalry among the sampled firms did not materially affect firm profitability, but that durin

Exploring the connection between frustra
Exploring the connection between frustration and consumer choice behavior in a dynamic decision environment
✍ Judi Strebel; Kathleen O'Donnell; John G. Myers πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 127 KB

## Abstract This research proposes that frustration during the purchase process for high‐technology durable goods has a significant effect on the probability that consumers will commit to a technology and make a purchase. In order to explore the effects of consumer frustration on the purchase proce

An empirical analysis of sustained advan
An empirical analysis of sustained advantage in the U.S. pharmaceutical industry: impact of firm resources and capabilities
✍ Poh-Lin Yeoh; Kendall Roth πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 110 KB πŸ‘ 3 views

The authors test a model of the relationships among firm resources, firm capabilities, and sustained competitive advantage between 1971 and 1989. Sustained comparative advantage was captured by two variables: therapeutic differentiation and global NCEs. The results show that R&D and salesforce expen